Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.
Acute Disseminated Encephalomyelitis in Children and Adolescents: A Single Center Experience.
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
Charcot-Marie-Tooth disease: Genetic and clinical spectrum in a Spanish clinical series.
The use of transcranial magnetic stimulation in diagnosis, prognostication and treatment evaluation in multiple sclerosis.
Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
The orphan G protein-coupled receptor GPR17 negatively regulates oligodendrocyte differentiation via Gαi/o and its downstream effector molecules.
Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course.
Eye-Mediated Induction of Specific Immune Tolerance to Encephalitogenic Antigens.
Frequent occurrence of cerebral demyelination in adrenomyeloneuropathy.
The epidemiology of alcohol consumption and multiple sclerosis: a review.
Alemtuzumab in the treatment of multiple sclerosis: key clinical trial results and considerations for use.
Neuronal activity biases axon selection for myelination in vivo.
Antibody biomarkers in CNS demyelinating diseases - a long and winding road.
Corrigendum to "Cardiovascular autonomic dysfunction in multiple sclerosis: A meta-analysis" [Mult. Scler. Relat. Disord. 4 (2015) 104-111].
Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Uric acid in relapsing-remitting multiple sclerosis: a 2-year longitudinal study.
Neuromyelitis optica: a positive appraisal of seronegative cases.
Cholesterol in myelin biogenesis and hypomyelinating disorders.
Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis.
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.
Antibodies to myelin oligodendrocyte glycoprotein are uncommon in Japanese opticospinal multiple sclerosis.
Relapses in multiple sclerosis: effects of high-dose steroids on cortical excitability.
Pages
« first
‹ previous
…
534
535
536
537
538
539
540
541
542
…
next ›
last »